<SEC-DOCUMENT>0001193125-20-249136-index.html : 20200918
<SEC-HEADER>0001193125-20-249136.hdr.sgml : 20200918
<ACCEPTANCE-DATETIME>20200918162351
ACCESSION NUMBER:		0001193125-20-249136
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200918
DATE AS OF CHANGE:		20200918

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Taysha Gene Therapies, Inc.
		CENTRAL INDEX KEY:			0001806310
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				843199512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39536
		FILM NUMBER:		201184264

	BUSINESS ADDRESS:	
		STREET 1:		7318 MORTON STREET
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75209
		BUSINESS PHONE:		212.551.8702

	MAIL ADDRESS:	
		STREET 1:		7318 MORTON STREET
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75209
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>d31596d8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
Document 1 - file: d31596d8a12b.htm

</DOCUMENT>
</SEC-DOCUMENT>